DAILIPORT

This brand name is authorized in Austria, Estonia, Finland, Lithuania, Netherlands, Poland, Turkey, United Kingdom

Active ingredients

The drug DAILIPORT contains one active pharmaceutical ingredient (API):

1 Tacrolimus monohydrate UNII WM0HAQ4WNM - TACROLIMUS

Tacrolimus is a highly potent immunosuppressive agent. In particular, tacrolimus inhibits the formation of cytotoxic lymphocytes, which are mainly responsible for graft rejection. Tacrolimus suppresses T-cell activation and T-helper-cell dependent B-cell proliferation, as well as the formation of lymphokines (such as interleukins-2, -3, and γ-interferon) and the expression of the interleukin-2 receptor. Read about Tacrolimus

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DAILIPORT Prolonged-release hard capsule	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L04AD02	Tacrolimus	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AD Calcineurin inhibitors
Discover more medicines within L04AD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1776607, 1776618, 1776629, 1776630, 1776641, 1776652, 1776663, 1776674, 1776685, 1776696, 1776708, 1776719, 1776720, 1776731, 1776742, 1776753, 1776764, 1776775, 1776786, 1776797
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 044310, 073881, 159369, 434757, 492253
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 379398, 379400, 379401, 379403, 379405, 379412
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1088730, 1088731, 1088732, 1088733, 1088734, 1088735, 1088736, 1088737, 1088738, 1088739, 1088740, 1088741, 1088742, 1088743, 1088744, 1088745, 1088746, 1088747, 1088748, 1088749, 1088750, 1088751, 1088752, 1088753, 1088754, 1088755, 1088756, 1088757, 1088758, 1088759, 1088760, 1088761, 1088762, 1088763, 1088764, 1088765, 1088766, 1088767, 1088768, 1088769
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 200719, 96148, 96156, 96164, 96172
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100409795, 100409803, 100409810, 100409826, 100409832
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681428171538, 8681428171545, 8681428171552, 8681428171569, 8681428171576, 8681428171583, 8681428171590, 8681428171606, 8681428171613, 8681428171620, 8681428171637, 8681428171644, 8681428171651, 8681428171668, 8681428171675